Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (321-330 of 433) with videos related to

Pageof 44
Sort By:
Journal of the National Cancer Institute|November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancerLindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group studyP A Burch, M Block, G Schroeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II studySteven R Alberts, William L Horvath, William C Sternfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT databaseNadine J McCleary, Jeffrey A Meyerhardt, Erin Green, et al.
Annals of Surgical Oncology|April 1, 2011
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146)Chee-Chee H Stucky, Barbara A Pockaj, Paul J Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
International Journal of Cancer|December 26, 2006
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Megan M Garrity-Park, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|March 1, 2006
An enhanced microsatellite map of diploid FragariaD J Sargent, J Clarke, D W Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT databaseQian Shi, Thierry Andre, Axel Grothey, et al.
Pageof 44

Showing results (321-330 of 433) with videos related to

Sort By:
Pageof 44
Journal of the National Cancer Institute|November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancerLindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group studyP A Burch, M Block, G Schroeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II studySteven R Alberts, William L Horvath, William C Sternfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT databaseNadine J McCleary, Jeffrey A Meyerhardt, Erin Green, et al.
Annals of Surgical Oncology|April 1, 2011
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146)Chee-Chee H Stucky, Barbara A Pockaj, Paul J Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
International Journal of Cancer|December 26, 2006
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Megan M Garrity-Park, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|March 1, 2006
An enhanced microsatellite map of diploid FragariaD J Sargent, J Clarke, D W Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT databaseQian Shi, Thierry Andre, Axel Grothey, et al.
Pageof 44